Concepedia

Anna R. Michmerhuizen

AR

Statistics

Publications

10

Citations

335

H-Index

10

Active since

2017

Affiliations

University of Michigan(Current)

Michigan Center for Translational Pathology

Calvin University

University of California, San Francisco

Anna R. Michmerhuizen is an author at University of Michigan specializing in oncology, tumor biology, and radiation therapy.

ORCID

Top concepts

Publications per year

2017–2022

10

Publications

10

TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

Benjamin C. Chandler, Leah Moubadder, Cassandra L. Ritter et al. · Journal of Clinical Investigation · 2020 · 83 citations · Full text

, , +14

PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation

Anna R. Michmerhuizen, Andrea M. Pesch, Leah Moubadder et al. · Molecular Cancer Therapeutics · 2019 · 55 citations · Full text

Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers

Andrea M. Pesch, Nicole Hirsh, Benjamin C. Chandler et al. · Clinical Cancer Research · 2020 · 52 citations · Full text

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells

Anna R. Michmerhuizen, Benjamin C. Chandler, Eric Olsen et al. · Frontiers in Endocrinology · 2020 · 36 citations · Full text

RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes

Andrea M. Pesch, Nicole Hirsh, Anna R. Michmerhuizen et al. · JCI Insight · 2021 · 28 citations · Full text

, , +16

1–5 of 10